Document is current
Any future updates will be listed below
-
Authors
Gauthier, Laurent https://orcid.org/0000-0003-3225-4825
Virone-Oddos, Angela https://orcid.org/0000-0002-4511-0612
Beninga, Jochen
Rossi, Benjamin
Nicolazzi, Céline
Amara, Céline
Blanchard-Alvarez, Audrey
Gourdin, Nicolas
Courta, Jacqueline
Basset, Alexandra
Agnel, Magali
Guillot, Franceline
Grondin, Gwendoline
Bonnevaux, Hélène https://orcid.org/0000-0002-4491-669X
Bauchet, Anne-Laure
Morel, Ariane
Morel, Yannis
Chiron, Marielle
Vivier, Eric https://orcid.org/0000-0001-7022-8287
- License Information
-
More Information
Article History
Received: 10 August 2022
Accepted: 23 November 2022
First Online: 12 January 2023
Competing interests
: L.G., B.R., A.B.-A., N.G., F.G., G.G., A.M., Y.M. and E.V. are employees of Innate Pharma. A.V.-O., M.C., M.A., J.B., C.N., C.A., J.C., A.B., H.B. and A.-L.B. are employees of SANOFI. L.G., B.R., A.M., A.V.-O., M.C., C.N., C.A. and J.B. hold patents related to multifunctional antibodies engaging NK cells (WO2022144836A1).
